Therefore, a generic Pharma company in Malta will develop a drug under the Maltese Patent and Design Act, complete all of the compulsory criteria for testing the required authorizations, and release their product on the market without unfair delay upon expiry of the competitor's patent. Visit : https://bit.ly/3ioIDIE